Excellent.......Thankyou Dr O, for the much-needed update!....Short term goals are being met, with higher than expected resluts, and long-term goals still in place...wouldn't surprise me, after the olympics, if they pursue another manufacturing deal....
Also like the cound of this:
"An Investigational New Drug ("IND") submission has been presented to the FDA for consideration. Four pre-clinical tests are likely to be required before human clinical trials can begin but the protocols have been established and are included in the submission. The Company is interested in the antiseptic market because Enturia, the company that brought the leading skin antiseptic to the market, was purchased by Cardinal Health for $490 Million in April, 2008."
News 
Market Data 
Discover 
